pacliccord
pharmacy retailing (nz) ltd t/a healthcare logistics - paclitaxel 6 mg/ml - concentrate for infusion - 6 mg/ml - active: paclitaxel 6 mg/ml excipient: ethanol polyoxyl 35 castor oil - paclitaxel is indicated for: primary treatment of ovarian cancer in combination with other chemotherapeutic agents. treatment of metastatic carcinoma of the ovary after failure of standard therapy.
oxaliplatin 5mg/ml concentrate for solution for infusion
accord healthcare ireland ltd. - oxaliplatin - concentrate for solution for infusion - 5 milligram(s)/millilitre - platinum compounds; oxaliplatin
oxaliplatin 5mg/ml concentrate for solution for infusion - (20ml vial)
accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents
oxaliplatin 5mg/ml concentrate for solution for infusion - (40ml vial)
accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents
oxaliplatin 5mg/ml concentrate for solution for infusion concentrate for solution for infusion
accord healthcare polska sp. z o.o. - oxaliplatin - concentrate for solution for infusion - 5mg/ml
oxaliplatin 5mg/ml concentrate for solution for infusion concentrate for solution for infusion
accord healthcare polska sp. z o.o. - oxaliplatin - concentrate for solution for infusion - 5mg/ml
robol (doxorubicin concentrate for solution for infusion 2mgml)
unimed sdn bhd - doxorubicin hydrochloride -
as-gemcitabine
viatris limited - gemcitabine hydrochloride 11.4 mg/ml equivalent to 10 mg/ml gemcitabine; - concentrate for injection - 10 mg/ml - active: gemcitabine hydrochloride 11.4 mg/ml equivalent to 10 mg/ml gemcitabine excipient: hydrochloric acid sodium acetate sodium hydroxide water for injection - gemcitabine, alone or in combination with cisplatin, is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer.
gemcitabine-pf
viatris limited - gemcitabine hydrochloride 11.4 mg/ml equivalent to 10 mg/ml gemcitabine; - concentrate for injection - 10 mg/ml - active: gemcitabine hydrochloride 11.4 mg/ml equivalent to 10 mg/ml gemcitabine excipient: hydrochloric acid sodium acetate sodium hydroxide water for injection - gemcitabine, alone or in combination with cisplatin, is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer.
gn-gemcitabine
viatris limited - gemcitabine hydrochloride 11.4 mg/ml equivalent to 10 mg/ml gemcitabine; - concentrate for injection - 10 mg/ml - active: gemcitabine hydrochloride 11.4 mg/ml equivalent to 10 mg/ml gemcitabine excipient: hydrochloric acid sodium acetate sodium hydroxide water for injection - gemcitabine, alone or in combination with cisplatin, is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer.